Shyam Aggarwal

Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations

Nishita Thota, Suhasini Singh, Shila Padhi et al. · Breast Cancer Research and Treatment · 2018 · 97 citations

Medicine, Genetics, Oncology +17

Open-label, multi-center, non-randomized, single-arm study to evaluate the safety and efficacy of dendritic cell immunotherapy in patients with refractory solid malignancies, on supportive care

P. P. Bapsy, Bandana Sharan, Chaitanya Kumar et al. · Cytotherapy · 2014 · 44 citations

Life Sciences, Immunology, Oncology +15

Prevalence of <i>BRCA1</i> and <i>BRCA2</i> Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study

Sudeep Gupta, Senthil Rajappa, Suresh H. Advani et al. · JCO Global Oncology · 2021 · 38 citations · Full text

Medicine, Genetics, Oncology +17

Clinical Experience with Gefitinib in Indian Patients

Purvish Parikh, Shona Nag, Raghunadharao Digumarti et al. · Journal of Thoracic Oncology · 2008 · 27 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +2

Protecting health-care professionals and workers (other than COVID-19 management facilities) from contamination during COVID-19 pandemic (March 26, 2020 – India)

Purvish M. Parikh, Prashant Mehta, Shweta Bansal et al. · Indian Journal of Medical Sciences · 2020 · 16 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +17